Agenda

New therapies, medical biotechnology, pharmaceuticals, clinical trials, and drug development. How can we shorten the path from basic and preclinical research to therapies available to patients? How can we foster collaboration between academia, pharmaceutical and biotechnology companies, hospitals, public agencies, and private investors?

Research funding, intellectual property, partnerships with major pharmaceutical companies, commercialisation, and reimbursement of innovative treatments.